Inventor
WAYKOLE LILADHAR MURLIDHAR
US19 patents
⚠️ This page may combine multiple inventors who share the name “WAYKOLE LILADHAR MURLIDHAR”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
NOVARTIS AG
13 patentsUS10947218B2Mar 16, 2021
Aminopyridine derivatives and their use as selective ALK-2 inhibitors
NOVARTIS AG6 citations81
US10710980B2Jul 14, 2020
Aminopyridine derivatives and their use as selective ALK-2 inhibitors
NOVARTIS AG8 citations81
US11548897B2Jan 10, 2023
Crystalline forms of a triazolopyrimidine compound
NOVARTIS AG0 citations62
US11091489B2Aug 17, 2021
Crystalline forms of a triazolopyrimidine compound
NOVARTIS AG0 citations62
US10934273B2Mar 2, 2021
Crystalline forms of 4-(2-((1R,2R)-2-hydroxycyclohexylamino)benzothiazol-6-yloxy)-N-methylpicolinamide
NOVARTIS AG0 citations61
US12466808B2Nov 11, 2025
Aminopyridine derivatives and their use as selective ALK-2 inhibitors
NOVARTIS AG0 citations60
US11021446B2Jun 1, 2021
Compositions and methods for modulating farnesoid X receptors
NOVARTIS AG0 citations60
US9802931B2Oct 31, 2017
Salts of aza-bicyclic di-aryl ethers and methods to make them or their precursors
NOVARTIS AG1 citations58
US11786498B2Oct 17, 2023
Sacubitril calcium salts
NOVARTIS AG0 citations56
US12187703B2Jan 7, 2025
Crystalline forms of N-(3-(2-(2-hydroxyethoxy)-6-morpholinopyridin-4-yl)-4-methvlphenyl)-2 (trifluoromethyl)isonicotinamide as Raf inhibitors for the treatment of cancer
NOVARTIS AG0 citations54
US11590158B2Feb 28, 2023
Pharmaceutical compositions of lipoic acid choline ester salts and methods of treatment using same
NOVARTIS AG0 citations53
US11135239B1Oct 5, 2021
Pharmaceutical compositions of lipoic acid choline ester salts and methods of treatment using same
NOVARTIS AG0 citations53
US10421755B2Sep 24, 2019
Salts of aza-bicyclic di-aryl ethers and methods to make them or their precursors
NOVARTIS AG0 citations48